Vitenskapelig artikkel

• Magiorkinis, Gkikas; Angelis, Konstantinos; Mamais, Ioannis et al. (2016). The global spread of HIV-1 subtype B epidemic. (ekstern lenke)
• Hofstra, L. Marije; Sauvageot, Nicolas; Albert, Jan et al. (2016). Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. (ekstern lenke)
• Angelis, Konstantinos; Albert, Jan; Mamais, Ioannis et al. (2015). Global dispersal pattern of HIV type 1 subtype CRF01-AE: A genetic trace of human mobility related to heterosexual sexual activities centralized in southeast Asia. (ekstern lenke)
• Frentz, Dineke; Vijver, David A. van de; Abecasis, Ana B. et al. (2014). Patterns of transmitted HIV drug resistance in Europe vary by risk group. (ekstern lenke)
• Frentz, Dineke; Vijver, David A.M.C. van de; Abecasis, Ana B. et al. (2014). Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. (ekstern lenke)
• Abecasis, Ana B.; Wensing, Annemarie M. J.; Paraskevis, Dimitris et al. (2013). HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. (ekstern lenke)
• Frentz, Dineke; Wensing, Annemarie M. J.; Albert, Jan et al. (2013). Limited cross-border infections in patients newly diagnosed with HIV in Europe. (ekstern lenke)
• Pathak, Sharad; Awuh, Jane Atesoh; Leversen, Nils Anders et al. (2012). Counting mycobacteria in infected human cells and mouse tissue: a comparison between qPCR and CFU. (ekstern lenke)
• Theys, Kristof; Deforche, Koen; Vercauteren, Jürgen et al. (2012). Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. (ekstern lenke)
• Salte, Tore; Pathak, Sharad; Wentzel-Larsen, Tore et al. (2011). Increased intracellular growth of Mycobacterium avium in HIV-1 exposed monocyte-derived dendritic cells. (ekstern lenke)
• Pathak, Sharad; Wentzel-Larsen, Tore; Åsjø, Birgitta (2010). Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages. (ekstern lenke)
• Paraskevis, Dimitrios; Pybus, Oliver; Magiorkinis, Gkikas et al. (2009). Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. (ekstern lenke)
• Vercauteren, Jürgen; Wensing, Annemarie M. J.; Vijver, David A. van de et al. (2009). Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe. (ekstern lenke)
• Myrmel, Helge; Ulvestad, Elling; Åsjø, Birgitta (2009). The hepatitis C virus enigma. (ekstern lenke)
• Pathak, Sharad; Souza, Gustavo De; Salte, Tore et al. (2009). HIV Induces both a Down-Regulation of IRAK-4 that Impairs TLR Signalling and an Up-regulation of the Antibiotic Peptide Dermcidin in Monocytic Cells. (ekstern lenke)
• Wensing, Annemarie M. J.; Vercauteren, Jürgen; Vijver, David A. van de et al. (2008). Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. (ekstern lenke)
• Baba, Kamaldeen; Pathak, Sharad; Sviland, Lisbet et al. (2008). Real-time quantitative PCR in the diagnosis of tuberculosis in formalin-fixed paraffin-embedded pleural tissue in patients from a high HIV endemic area. (ekstern lenke)
• Vijver, David A. van de; Wensing, Annemarie M. J.; Angarano, Gioacchino et al. (2006). The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. (ekstern lenke)
• Voltersvik, Pål; Bostad, Leif; Riise, Anne Ma Dyrhol et al. (2006). Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy. (ekstern lenke)
• Myrmel, Helge; Navaratnam, Vasanthan; Åsjø, Eva Birgitta (2005). Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). (ekstern lenke)
• Wensing, Annemarie M.J.; Vijver, David A. van de; Angarano, Gioacchino et al. (2005). Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. (ekstern lenke)
• Lugada, Eric Stephen; Mermin, Johathan; Kaharuza, F. et al. (2004). Population-based hematologic and immunologic reference values for a healthy Ugandan population. (ekstern lenke)
• Lugada, Eric Stephen; Mermin, Johathan; Åsjø, Eva Birgitta et al. (2004). Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway. (ekstern lenke)
• Ormaasen, Vidar; Åsjø, Eva Birgitta; Asjo, B et al. (2004). An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy. (ekstern lenke)
• Vandamme, Annemarie; Sönnerborg, Anders; Ait-Khaled, M et al. (2004). Updated European recommendations for the clinical use of HIV drug resistance testing. (ekstern lenke)
• Andersson, S; Åsjø, Eva Birgitta; Jenum, AK et al. (2004). Relevance of a combined HIV antigen/antibody assay to detect early HIV infection in a low prevalence population: Case reports. (ekstern lenke)
• Voltersvik, Pål; Albrektsen, Grethe; Ulvestad, Elling et al. (2003). Changes in Immunoglobulin isotypes and Immunoglobulin G (IgG) subclasses during Highly Active Antiretroviral Therapy. Anti-p24 IgG1 closely parallells the biphasic decline in plasma viremia. (ekstern lenke)
• Åsjø, Eva Birgitta; Stavang, Helen; Sørensen, Birger et al. (2002). Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral Therapy. (ekstern lenke)
• Dyrhol-Riise, Anne Ma; Voltersvik, Pål; Berg, Ole G. et al. (2001). Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization. (ekstern lenke)
• Dyrhol-Riise, Anne Ma; Stent, Gianna; Røsok, Bård Ingvald et al. (2001). The Fas/FasL System and T Cell Apoptosis in HIV-1-Infected Lymphoid Tissue during Highly Active Antiretroviral Therapy. (ekstern lenke)
• Åsjø, Eva Birgitta; Ulvestad, Elling (2001). HIV-1 resistens mot antiretrovirale midler. (ekstern lenke)
• Jonassen, TO; Grinde, Bjørn; Åsjø, Eva Birgitta et al. (2000). Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases. (ekstern lenke)
• Bruu, AL; Hjetland, R; Holter, E et al. (2000). Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific heterophile antibodies. (ekstern lenke)
• Coul, E Op De; Burg, R van den; Åsjø, Eva Birgitta et al. (2000). Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children. (ekstern lenke)
• Dyrhol-Riise, Anne Ma; Brantsaeter, AB; Dunlop, O et al. (2000). Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals. (ekstern lenke)
• Dyrhol-Riise, Anne Ma; Voltersvik, Pål; Røsok, Bård Ingvald et al. (2000). Normalization of CD4+ Cell Numbers and Reduced Levels of Memory CD8+ Cells in Blood and Tonsillar Tissue after Highly Active Antiretroviral Therapy in Early HIV Type-1 Infection. (ekstern lenke)
• Holm-Hansen, Carol; Baan, Elly; Åsjø, Eva Birgitta et al. (2000). Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region. (ekstern lenke)
• Holm-Hansen, Carol; Stern, Beate; Rustad, Siren et al. (2000). V3 sequence analysis and biological characterization of HIV-1 isolates from asymptomatic and early symptomatic Tanzanian individuals. (ekstern lenke)
• Voltersvik, Pål; Dyrhol-Riise, Anne Ma; Bostad, Leif et al. (2000). Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy. (ekstern lenke)
• Riise, Anne Ma Dyrhol; Voltersvik, Pål; Olofsson, Jan et al. (1999). Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. (ekstern lenke)
• Nilsen, MV; Åsjø, Eva Birgitta; Sommerfelt, Maja A (1999). Transient Tat activation of the HIVLAV/Lai-1 LTR by primary HIV-1 phenotypic variants in HeLaT4LTR_b-gal cells. (ekstern lenke)

Rapport

• Vik, Inger Sofie Samdal; Dudman, Susan G.; Litleskare, Irene et al. (2015). Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2013–2014. RAVN 2013-2014. (ekstern lenke)
• Kilander, Anette; Dudman, Susanne Gjeruldsen; Stene-Johansen, Kathrine et al. (2013). Usage of antivirals and the occurrence of antiviral resistance in Norway 2011-2012. RAVN 2011–12. (ekstern lenke)
• Haukenes, Gunnar; Åsjø, Eva Birgitta; Holm-Samdal, H et al. (1998). HIV-infeksjon, en strategirapport. (ekstern lenke)

Poster

• Pathak, Sharad; Leversen, Nils Anders; Wiker, Harald G et al. (2008). Rapid and reliable quantification of Mycobacteria inside macrophages in vitro and mice mice using real-taime quantitative PCR. (ekstern lenke)
• Pathak, Sharad; Leversen, Nils Anders; Wiker, Harald G et al. (2008). Rapid and reliable quantification of mycobacteria inside macrophages in vitro and mice using real-time quantitative PCR. (ekstern lenke)
• Voltersvik, Pål; Bostad, Leif; Riise, Anne Ma Dyrhol et al. (2006). Cathepsin B and Cystatin A as indicators of a separate apoptotic pathway in HIV-1 infection. (ekstern lenke)
• Åsjø, Eva Birgitta; Voltersvik, Pål; Bostad, Leif (2005). Cathepsin B and Cystatin A as indicators of a separate apoptotic pathway in HIV-1 infection. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Åsjø, Birgitta; Langeland, Nina (2008). Medikamentell resistens vid HIV-infektion. (ekstern lenke)

Sammendrag/Abstract

• Wensing, Annemarie M. J.; Vercauteren, J.; Vijver, David A. van de et al. (2006). Transmission of drug-resistance in Europe is characterized by single mutations and revertants. (ekstern lenke)

Intervju

• Åsjø, Eva Birgitta (2005). Intervju i Dagsnytt 18 om HIV-resistens, Svartedauen och selektion av mutation. (ekstern lenke)
• Åsjø, Eva Birgitta (2005). Fight AIDS @ home. (ekstern lenke)
• Åsjø, Eva Birgitta (2005). Fight AIDS @ home. (ekstern lenke)
• Åsjø, Eva Birgitta (2005). Intervju med anledning av Nelson Mandelas besök och HIV-situationen i Afrika. (ekstern lenke)
• Åsjø, Eva Birgitta (2005). Biodiversitet och nya virus. (ekstern lenke)
• Åsjø, Eva Birgitta (2005). Intervju i Vert å Vite om HIV och bushmeat. (ekstern lenke)
• Åsjø, Eva Birgitta (2005). Intervju i Vert å Vite om nya virus. (ekstern lenke)

Populærvitenskapelig artikkel

• Åsjø, Eva Birgitta (2005). HIV-gåtan och nya virus. (ekstern lenke)

Programdeltagelse

• Åsjø, Eva Birgitta (2005). HIV-gåtan och nya virus. (ekstern lenke)

Leserinnlegg

• Crowe, Susanne M.; Åsjø, Eva Birgitta (2004). Locking the door to HIV entry: how far can we go?. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Haukenes, Gunnar; Kalland, Karl-Henning; Åsjø, Eva Birgitta et al. (1998). Mikrobiologisk diagnostikk. Kapittel om Nukleinsyrebasert diagnostikk. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin